Author: Brian “Weence” Bateman

Brian “Weence” Bateman is a health and medical writer who covers public health updates, healthcare policy, and medical developments affecting communities across the United States. He works closely with dentists and healthcare providers and focuses on making complex medical information clear, accurate, and useful for everyday readers.

Screening & Prevention Guidelines

Long COVID Brain Fog: When to Ask About Cognitive Rehab (Trial Data + Next Steps)
July 30, 2026 2:46 pm

If your “brain fog” symptoms have lasted 4+ weeks after COVID, U.S. guidance supports talking with a clinician about evaluation and support. A new randomized trial in JAMA Network Open found goal-focused cognitive rehab delivered by telehealth improved participants’ self-reported goal attainment, while changes in other cognitive tests and symptoms were less consistent. Here’s what to ask about—especially if you have post-exertional malaise (PEM).

Read More Long COVID Brain Fog: When to Ask About Cognitive Rehab (Trial Data + Next Steps)
Drug Safety, Shortages & Recalls

Cetirizine Recall: Check Lots and Get Help for Anaphylaxis Symptoms
July 30, 2026 1:48 pm

The FDA says four lots of cetirizine 5 mg tablets may be contaminated with ranitidine. Check your bottle’s NDC and lot number, and know the emergency signs of a serious allergic reaction—especially if you’ve had reactions to ranitidine.

Read More Cetirizine Recall: Check Lots and Get Help for Anaphylaxis Symptoms
Health Costs & Coverage

No Surprises Act Update (July 2026): What CMS’ $15 IDR Fee Rules Mean
July 30, 2026 1:02 pm

CMS’ mid-July 2026 notice clarifies the federal Independent Dispute Resolution (IDR) administrative fee for certain No Surprises Act disputes. For disputes initiated on or after June 11, 2026, the federal IDR fee is $15 per party per dispute—plus practical steps if you receive a bill that looks like a surprise bill.

Read More No Surprises Act Update (July 2026): What CMS’ $15 IDR Fee Rules Mean
Drug Safety, Shortages & Recalls

FDA Recall: Baxter Cefazolin IV Bags With Cardboard Particles—Next Steps
July 30, 2026 10:36 am

FDA says Baxter is voluntarily recalling one lot of cefazolin in dextrose IV bags after cardboard-like particles were found in the solution. If you still have the product, stop using it and return it as instructed. If you received it during surgery, contact your facility for lot-specific information—and seek emergency care for symptoms that could signal a pulmonary embolism (like sudden shortness of breath or chest pain).

Read More FDA Recall: Baxter Cefazolin IV Bags With Cardboard Particles—Next Steps
Public Health & Prevention

CDC Update: Overall Respiratory Illness Is Very Low, but PIV and Pertussis Are Up
July 30, 2026 8:07 am

CDC’s July 24, 2026 snapshot says overall acute respiratory illness needing care is very low—but it also flags elevated parainfluenza (PIV) activity and ongoing pertussis (whooping cough) circulation. Here are calm, practical steps families and schools can take now, plus when to seek urgent help.

Read More CDC Update: Overall Respiratory Illness Is Very Low, but PIV and Pertussis Are Up
Nutrition & Dietary Guidance

FDA cleared an OTC CGM for kids: using glucose trends safely
July 29, 2026 6:41 pm

On June 12, 2026, the FDA cleared the first over-the-counter (OTC) continuous glucose monitor for children (age 2+ who do not use insulin). Here’s how parents can use glucose trends around meals and activity responsibly—without overreacting to single readings or making unsafe medication changes.

Read More FDA cleared an OTC CGM for kids: using glucose trends safely
Outbreaks & Health Alerts

GreenWise Frozen Blueberries Recall: E. coli Symptoms & When to Get Help
July 29, 2026 5:32 pm

If you ate recalled GreenWise frozen organic blueberries (10 oz, lot 60401, best by Feb. 9, 2028), know when symptoms may start (often 3–4 days) and which signs—especially dehydration and HUS—mean you need medical help right away.

Read More GreenWise Frozen Blueberries Recall: E. coli Symptoms & When to Get Help
Clinical Trials

Long COVID Brain Fog Trial: Telehealth Goal Rehab Results
July 29, 2026 3:33 pm

A new randomized trial tested a remote, individualized “goal-focused” cognitive rehab program for adults with long COVID–related cognitive impairment (often called “brain fog”). Participants reported better functional goal attainment after treatment, with benefits still seen at 6 months. But the trial did not show broad improvements across all cognitive tests—and it did not find significant group differences for symptoms such as fatigue or post-exertional malaise (PEM). Here’s what that means for U.S. readers considering goal-based rehab.

Read More Long COVID Brain Fog Trial: Telehealth Goal Rehab Results
Healthcare Policy & Access

Hospital Price Transparency Enforcement: What CMS Tracks—and What It Can’t Predict
July 29, 2026 12:17 pm

CMS’s hospital price transparency enforcement is tied to updated 2026 requirements, and CMS publishes enforcement outcomes in a public dataset. Here’s how to read those warnings and penalty pathways—and how to use posted prices responsibly when estimating costs.

Read More Hospital Price Transparency Enforcement: What CMS Tracks—and What It Can’t Predict
Drug Safety & Recalls

FDA Recall: Check Cetirizine Bottle for Ranitidine Cross-Contamination
July 29, 2026 10:58 am

FDA says four lots of cetirizine 5 mg tablets were recalled because of possible ranitidine cross-contamination. Check your lot number, stop if it matches, and call 911 for signs of anaphylaxis.

Read More FDA Recall: Check Cetirizine Bottle for Ranitidine Cross-Contamination
Outbreaks & Health Alerts

Cyclospora Outbreak Linked to Recalled Lettuce: What Families Should Do
July 29, 2026 9:37 am

CDC, FDA, and state partners are investigating a Cyclospora outbreak linked to recalled iceberg lettuce in 9 states. If your household ate the recalled shredded lettuce, here’s what to watch for and what to do now.

Read More Cyclospora Outbreak Linked to Recalled Lettuce: What Families Should Do
Medical Research & Studies

Recalled Kids’ Fruit Pouches: How to Check Pumpkin Tree Banana & Strawberry
July 28, 2026 4:17 pm

FDA posted a July 21, 2026 recall for select Pumpkin Tree Peter Rabbit Organics Banana & Strawberry 4 oz fruit puree pouches due to a possible soft, food-grade plastic strand. Here’s how to check, what to do if you have one, and what symptoms mean urgent care.

Read More Recalled Kids’ Fruit Pouches: How to Check Pumpkin Tree Banana & Strawberry
Nutrition & Dietary Guidance

Pregnant or 65+? Checklist for Requeson/Soft Ricotta and Listeria
July 28, 2026 12:32 pm

CDC and FDA are investigating a multistate Listeria outbreak linked to certain requeson/soft ricotta-style cheeses. If you’re pregnant, 65 or older, or immunocompromised, check your fridge, do not eat recalled cheese, and know which symptoms mean you should contact a clinician right away.

Read More Pregnant or 65+? Checklist for Requeson/Soft Ricotta and Listeria
Emergency Preparedness & Response

Measles Wastewater Update: What Families and Schools Can Do Now
July 28, 2026 8:26 am

CDC updates its measles wastewater monitoring data every Friday. This guide explains what a detection (or no detection) can suggest for community-level measles activity—and what families and schools should do next to stay ready without panicking.

Read More Measles Wastewater Update: What Families and Schools Can Do Now
Neurology

If You Have Maternal Venezuelan Ancestry: What the FDA’s July 2026 Anesthesia Safety Alert Means for Families
July 27, 2026 5:02 pm

On July 2, 2026, the FDA said it is investigating rare, catastrophic neurologic outcomes after general anesthesia—especially involving sevoflurane/volatile anesthetics—in some people with maternal Venezuelan ancestry. Here’s what’s known, what remains uncertain, what professional guidance recommends discussing before surgery, and the stroke-like “red flags” that should trigger a call to 911 after anesthesia.

Read More If You Have Maternal Venezuelan Ancestry: What the FDA’s July 2026 Anesthesia Safety Alert Means for Families
Medical Research & Clinical Studies

Nara Organics recall: infant botulism signs and when to get urgent care
July 27, 2026 4:23 pm

If your baby drank Nara Organics recalled powdered formula, here are the infant botulism warning signs to watch for, how long to monitor, and when to seek emergency care.

Read More Nara Organics recall: infant botulism signs and when to get urgent care
Screening & Prevention Guidelines

Positive at-home HPV tests: next steps and 2027 follow-up coverage
July 27, 2026 3:53 pm

A positive result on an FDA-cleared at-home HPV self-collection test doesn’t mean you have cancer. What matters next is completing the screening pathway with follow-up care—and starting January 1, 2027, HRSA’s updated guidance aims to reduce cost barriers for the additional testing needed to complete screening for many people with insurance.

Read More Positive at-home HPV tests: next steps and 2027 follow-up coverage
Rural Health & Access

Can’t Find Hospital Prices Online? CMS Price Transparency Steps for 2026
July 27, 2026 1:16 pm

If you can’t find your hospital’s required pricing information online, CMS has a complaint contact path—and 2026 enforcement updates increase the odds that required “standard charges” should be posted. Here’s what to check, what to document, and how rural patients can plan for costs even when transparency data is incomplete.

Read More Can’t Find Hospital Prices Online? CMS Price Transparency Steps for 2026
Prescriptions

FDA Kidney Warning for Orlistat (Alli/Xenical): Symptoms to Know
July 27, 2026 10:55 am

On June 10, 2026, the FDA approved new labeling for the OTC weight-loss drug alli (orlistat 60 mg) warning about rare but serious kidney injury and kidney stones. The warning also aligns across FDA-approved orlistat products, including prescription Xenical. If you have kidney disease or a history of kidney stones, ask a clinician before using orlistat—and know the symptom checklist that should trigger prompt medical evaluation.

Read More FDA Kidney Warning for Orlistat (Alli/Xenical): Symptoms to Know
Immunization Policy & Access

VFC for Underinsured Kids (2026–27): Where to Go and What Fees to Expect
July 27, 2026 9:27 am

If your child is underinsured, VFC can still help cover the vaccine itself—often through FQHCs/RHCs and other deputized locations. Here’s what families may be billed for (and what to ask before school-year appointments).

Read More VFC for Underinsured Kids (2026–27): Where to Go and What Fees to Expect
Cancer

Sunburn With Blisters: How Long It Lasts, Normal vs. Warning Signs
July 26, 2026 5:03 pm

Blistering sunburn is a sign of significant UV damage. Here’s the typical timeline, which symptoms mean you should get medical care, and what research says about future skin cancer risk.

Read More Sunburn With Blisters: How Long It Lasts, Normal vs. Warning Signs
Long COVID & Post-Viral Conditions

Long COVID Brain Fog: July 2026 Trial on Goal-Focused Rehab
July 26, 2026 3:08 pm

A July 2026 randomized trial found that goal-focused cognitive rehabilitation improved long COVID–related brain fog outcomes at 3 months—and the benefit was sustained at 6 months. The study is small and has limitations, so it’s best viewed as promising evidence. Here’s how to use this information to ask better questions about assessment, referrals (like OT/SLP), and ruling out other causes with a U.S. clinician.

Read More Long COVID Brain Fog: July 2026 Trial on Goal-Focused Rehab

End of content